Valyl-, isoleucyl-, and leucyl-tRNA synthetase activities were examined in an Escherichia coli K-12 strain that possessed a deletion of three genes of the ilv gene cluster, ilvD, A, and C, and in a strain with the same deletion that also carried the XdilvCB bacteriophage. It was observed that the branched-chain tRNA synthetase activities of both strains were considerably less than those of the normal strain during growth in unrestricted medium. Furthermore, during an isoleucine limitation, there was a further reduction in isoleucyl-tRNA synthetase activity and an absence of the isoleucine-mediated derepression of valyl-tRNA synthetase formation in both of these mutants, as compared with the normal strain. In addition, it was observed that these branched-chain synthetase activities were reduced in steady-state cultures of several ilvA point mutants. However, upon the introduction of the ilv operon to these ilvA mutants by use of lambda bacteriophage, there was a specific increase in the branched-chain synthetase activities to levels comparable to those of the normal strain. These results support our previous findings that the stability and repression control of synthesis of these synthetases require some product(s) missing in the ilvDAC deletion strain and strongly suggest this component is some form of the ilvA gene product, threonine deaminase.
In both Escherichia coli and Salmonella typhimurium, the synthesis of valyl-, isoleucyl-, and leucyl-tRNA synthetases (VRS, IRS, and LRS, respectively) is subject to a repression control process similar to that for repression control of the ilv and leu gene products (2, 6, 16, 17, 19, 26) . In addition, Parker et al. (20, 21) and Reeh et al. (23) have shown that the formation of these tRNA synthetases is subject to metabolic regulation and responsive to nutritional enrichment. Furthermore, modes of metabolic regulation have been reported for lysyl-tRNA synthetase of E. coli (8) and for most of the aminoacyl-tRNA synthetases of bakers' yeast (10) .
For the branched-chain amino acid-mediated repression control process, VRS formation is multivalently controlled by the supply of both valine and isoleucine, whereas IRS and LRS formation is derepressed in specific response to a growth rate-limiting supply of the respective branched-chain amino acid (16, 17) . That (9) have reported that some regulatory mutants, with mutations not linked to the structural genes for the ilv and leu clusters or to those for the three branched-chain tRNA synthetases, exhibit altered repression control of both classes of branched-chain enzymes.
(ii) Levinthal et al. (13, 14) have shown that the ilvA gene product, threonine deaminase, is essential for generation of the derepression signal(s) for VRS, IRS, and LRS formation as well as that for the ilv and leu biosynthetic enzymes. However, it was not clear whether threonine deaminase had a direct role in regulating synthesis of these enzymes. (iii) More recently, Coleman et al. (3) reported that these tRNA synthetases exhibited altered stability of activity and control of synthesis in an E. coli strain deleted for the ilvD, -A, and -C genes. plemented with L-vahne (100 Jig/ml), L-isoleucine (50 ,ug/ml), and L-leucine (100 jug/ml). Specific amino acid limitations were achieved by use of glycyl-DL-amino acid (branched-chain) as described earlier (16, 17) . The culture conditions, measurement of growth, and BRANCHED-CHAIN SYNTHETASES 93 cell extract preparation followed previously described methods (16, 17) . The determination of protein content of extracts (15) , measurement of aminoacyl-tRNA synthetase activity (16) , and the growth procedures for deuterium oxide-to-water media transfers (27) were as previously described.
Centrifugation in CsCl and measurement of the rate of enzyme synthesis. Centrifugation and measurement of the rate of enzyme synthesis were as described by WiUiams and Neidhardt (27) Activities of VRS, IRS, and LRS of the ilvDAC deletion strain as compared with a strain with the same deletion that also carries AdilvCB. We initially examined the activities of the tRNA synthetases of the normal (CU367) and ilvDAC deletion/AdilvCB (CU464) strain grown in minimal medium supplemented with excess amounts of isoleucine, valine, and leucine. The ilvDAC deletion AdilvCB strain maintained VRS, IRS, and LRS activities at 59, 54, and 63%, respectively, of the levels of the corresponding activities in the normal strain ( Table 2 ). This result is identical to that ob- tained with strain CU356, which possesses the ilvDAC deletion alone ( Table 2 ). The rather small differences observed for histidyl-and arginyl-tRNA synthetase (HRS and ARS, respectively) activities of these two deletion strains clearly indicate that this reduction in activity is specific to the branched-chain tRNA synthetases.
Measurement of the de novo rate of synthesis and stability of VRS, IRS, and LRS. In view of our previous findings (3) that growth of strain CU356 with limiting amounts of isoleucine, valine, or leucine caused a further reduction in these synthetase activities and an altered control of synthesis of these enzymes, we examined the effect of an isoleucine limitation on the activity and rate of synthesis of these synthetases in strain CU464, which contains a normal ilvC genes and displays a gene dosage effect (bacterial and phage) for the ilvB gene. The rationale for the imposition of an isoleucine limitation on this mutant strain is as follows: (i) an isoleucine limitation has been shown to specifically affect the stability of the corresponding synthetase activity, and (ii) an isoleucine-limiting signal causes derepression of synthesis of both IRS and VRS in a normal strain (16, 17) . Upon an isoleucine limitation ofthis strain, there was a loss of IRS activity (Fig. 1) . In contrast, the rates of formation of LRS, ARS, and HRS were essentially unchanged. More importantly, the rate of VRS formation was not derepressed in response to the limiting-isoleucine signal. Both of these results (i.e., loss of IRS activity and lack of derepression of VRS formation) are in contrast to the response of these activities during isoleucine-limited growth of a normal strain (16, 17) . However, the fact that these results are identical to those obtained with strain CU356 (ilvDAC deletion alone) indicates that the ilvC and ilvB gene products have no role in the regulatory responses of this mutant strain. Furthermore, since the response of the repression control process to branched-chain amino acid limitations and the apparent stability of the branched-chain tRNA synthetase activities in an ilvD mutant are the same as those observed for a normal strain and ilvC mutants (results not shown), these data suggest that the ilvD gene product also has no role in generating the altered regulatory responses of these deletion mutants.
The essentially unchanged differential rate of VRS formation shown in Fig. 1 these two possibilities, we performed density labeling studies. Strains CU367 and CU464 were adapted to growth in 80% deuterium oxide (D20) medium, and the D20-to-water transfers were conducted as described earlier (27) . Figure 2A shows the band of IRS activity found in CsCl gradients of samples collected during growth in D20-unrestricted medium for strain CU464 (ilvDAC deletion/AdilvCB). Figures 2B and C show this activity in samples collected after 25 and 50% increases in mass, respectively, following the transfer from D20-unrestricted to isoleucine-limited water media. It is quite obvious that there was considerable inactivation of IRS activity (i.e., loss of IRS activity at a rate in excess of that predicted by the rate of dilution due to cell growth) during one-half generation ofisoleucinelimited growth of strain CU464. As expected from previous experiments, the normal strain (CU367) exhibited a severalfold increase (derepression) of IRS synthesis, and there was not evidence of inactivation of this activity even during two generations of isoleucine-limited growth (Fig. 2) signal is provided in Fig. 3 . The CsCl gradient profiles of VRS in samples taken during growth in D20-unrestricted (A) and isoleucine-restricted water (B and C) media for strain CU464 clearly indicate that there was little (if any) inactivation of this activity during a 50% mass increase in isoleucine-restricted medium. More significantly, as judged from the rate of appearance of light (newly synthesized) enzyme in these gradients, there was no derepression of VRS formation in this mutant grown with limiting amounts of L-isoleucine ( Fig. 3B and C) . This lack or response of VRS formation to an isoleucine limitation in this mutant carrying normal ilvC and ilvB genes is identical to that observed for the ilvDAC deletion strain, but in striking contrast to the regulatory patterns of a normal strain (3, 16, 17) . In addition, the results shown in Fig. 4 indicate that the rate of LRS formation was unaffected by isoleucine-limited growth of this ilvDAC deletion/XdilvCB strain (CU464). This observation is exactly the same as that observed for the strain with this ilvDAC deletion alone. That there was no significant inactivation of LRS activity in this mutant ( (Table 4) indicate that, upon an isoleucine limitation, VRS synthesis was derepressed in each mutant, while IRS formation was generally refractory to the limiting isoleucine signal. As expected, synthesis of LRS, ARS, and HRS was unaltered during isoleucine-limited growth ( Table 4) .
The reduced VRS and IRS activities of these ilvA mutants could be explained by (i) a decreased in vivo stability and/or (ii) a reduced rate of synthesis. There is a direct correlation between the functional state of threonine deaminase, the ilvA gene product, and the rate of synthesis of VRS and IRS (e.g., strains CU367, CU406, and CU514) during unrestricted growth (Table 5) . Thus, these results (Tables 4 and 5 ) clearly show that some mutations in ilvA, conferring an altered form and/or reduced amounts of threonine deaminase, have no affect on the leucine-specific repression control of LRS synthesis and confer no change in the stability of VOL. 134, 1978 this synthetase in such mutants. However, such mutations lead to a reduced rate of formation of VRS, even though its synthesis remains responsive to the supply of valine and isoleucine (i.e., multivalent control by these two amino acids is unaltered). In contrast, IRS formation is refractory to the isoleucine-mediated derepression signal(s), and its rate of synthesis is reduced relative to that of the normal strain (i.e., wild-type ilvA gene).
DISCUSSION
We have previously shown that synthesis of VRS, IRS, and LRS is controlled by a repression process in a parallel but noncoordinate fashion with controlled synthesis of the isoleucine-, valine-, and leucine-forming enzymes (2, 6, 16) . In addition to these noncoordinate patterns of control, the regulation of these tRNA synthetases differs from multivalent repression control of the ilv and leu biosynthetic enzymes in the following respects. Among these three tRNA synthetases, only the control of VRS formation is multivalent in nature, requiring both valine and isoleucine for complete repression (16, 17) . Repression control of IRS and LRS formation is mediated by the supply of the respective branched-chain amino acid (16, 17) . However, it has been observed that several mutations, unlinked to the ilv and leu operons as well as the valS, leuS, and ileS genes, confer altered regulatory patterns for both classes (i.e., biosynthetic and synthetase) of these branched-chain enzymes (9; L. S. Williams, E. Kline, and H. E. Umbarger, manuscript in preparation). Consistent with models that postulate the involvement of aminoacylated tRNAVaJ, tRNAIAU, and tRNA11 in repression control of the ilv and leu gene products (2, 4, 7, 27) , one could explain the parallel alterations in regulation of both classes of these enzymes in some of these mutants by "cause and effect relations." Specifically, some of these mutations may be in genes encoding elements specific for synthetase regulation. Thus, changes in the repression/derepression mode for the ilv and leu gene products may be the result of deficient or excess aminoacylation of specific isoaccepting species of tRNAVal, tRNAIAU, and tRNAIe, owing to alterations in the levels of the branched-chain tRNA synthetases.
Other observations reported for these two classes of enzymes are not easily explained by the above model. Levinthal et al. (13, 14) have shown that a mutation in ilvA, the structural gene for threonine deaminase, altered the derepression responses valS, ileS, and leuS and the ilv and leu operons. These results lead to the suggestion that threonine deaminase has a pos- control ofsynthesis, were due to absence of these three ilv-specific gene products. In view of other results, we suggested that these observations could be reasonably explained by the absence of threonine deaminase in this deletion mutant (9, 13, 14) .
In the present paper, we report that introduction of the ilvC gene (via AdilvCB bacteriophage) to this ilvDAC deletion strain was not sufficient to restore the normal steady-state unrestricted levels of these synthetases. In fact, upon an isoleucine limitation of this strain, IRS activity was further inactivated, and the cells were unable to elicit derepression of VRS formation. Both of these results are identical to those found for the deletion strain missing the ilvD, -A, and -C gene products. Furthermore, since there were no detectable alterations in activity or synthesis of these synthetases in ilvD mutants, we further suggest that the product of this gene has no role in the regulatory responses of this ilvDAC deletion mutant. It would, therefore, appear reasonable to ascribe these alterations in stability of activity and control of synthesis of IRS, VRS, and LRS to the absence of threonine deaminase in these mutants. Furthermore, in each mutant strain examined, a single point mutation in ilvA caused a reduction in VRS and IRS activities. That these activity changes were due to the mutation in ilvA is supported by the observation that the introduction of the ilv operon in such mutants restored these synthetase activities to the normal levels. It is then suggested that the in vivo activity of VRS as well as IRS is mediated by a functional threonine deaminase, which serves as a regulatory effector for these synthetases.
Based on the results reported by Levinthal et al. (13, 14) and Coleman et al. (3) and those of the present report, it is suggested that all these observations could be explained by the following 98 WILLIAMS, WHITFIELD, AND WILLIAMS model. Repression of synthesis of the branchedchain tRNA synthetases results from the formation of complexes (regulatory) between threonine deaminase: val-tRNAVI and tRNA11 for VRS; threonine deaminase: ile-tRNA" for IRS; and threonine deaminase: leu-tRNAIAu for LRS.
On the other hand, branched-chain amino acidspecific derepression of synthesis would be mediated by a complex of threonine deaminase and the respective branched-chain tRNA synthetases as free molecules (Eo), owing to the reduction in the supply of these amino acids (i.e., "low pools" of aminoacyl-adenylates and aminoacyl-tRNA's). In this respect, these synthetases would serve as positive control elements for their own synthesis (autoregulatory). This model is supported in part by recent indications of the existence of complexes of threonine deaminase and specific branched-chain tRNA synthetases (L. Dickson and L. S. Williams, unpublished data).
Furthermore, with the exception of studies employing hisT(tRNA) mutants (4, 24) and certain azaleucine-resistant isolates (L. S. Williams and H. E. Umbarger, unpublished data), most reports on the role of aminoacylated tRNAVaI, tRNA1e, and tRNAIAU in repression control of the ilv and leu operons do not exclude the direct involvement of IRS, VRS, and LRS in these control processes. It is possible that these enzymes have a direct role in the generation of the repression control signal(s) for these biosynthetic operons. This suggestion should be viewed in the context of recent reports that the isoleucine-valine (25) as well as the histidine (11) and tryptophan (1, 12, 18, 22) operons contain a positive control element in addition to a "classical-repressor recognition site" leading to dual control mechanisms for expression of these operons.
